Saint Kitts and Nevis vs Saint Lucia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Saint Kitts and Nevis
0.2%
in 2024
Saint Lucia
0.2%
in 2024
Saint Kitts and Nevis rank
98th
Saint Lucia rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Saint Kitts and Nevis
- Saint Lucia
How they compare
Saint Kitts and Nevis currently reports 0.2% against 0.2% in Saint Lucia, a difference of 0.0%.
Across all 10 years both countries report, Saint Lucia has been ahead every year.
Saint Kitts and Nevis ranks 98th and Saint Lucia ranks 98th of 246 countries.
Head to head by decade
| Decade | Saint Kitts and Nevis | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Saint Kitts and Nevis or Saint Lucia?
- Saint Kitts and Nevis, at 0.2% against 0.2% in Saint Lucia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Saint Kitts and Nevis and Saint Lucia?
- 0.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Saint Lucia?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Kitts and Nevis and Saint Lucia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Saint Kitts and Nevis ranks 98th and Saint Lucia ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.